Business

NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle

22 hours ago15 views0

NeuroScientific Biopharmaceuticals has landed key US backing for its Phase 2 stem cell Crohn’s trial, green-lighting a planned year-end start subject to final preparations.

Business / Companies

Brisbane Times – Business

Flying to Europe via the Middle East? Cheaper fares beat safety concerns

As the conflict in the Middle East rages on, travellers are increasingly unfazed and unwilling ...

7 hours ago

Business

I’m sick of immigration being blamed for problems it doesn’t cause

But the resurrection of Pauline Hanson and her ratbag One Nation has changed all that, ...

8 hours ago

Business

ASX set to slide as Wall Street slips

The first big batch of summertime profit reports from US companies is making waves on ...

8 hours ago

Now Reading

NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle

1min read

0 %

NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle

Notorious childcare paedophile to face trial in NSW

Man accused of pushing woman down set of stairs at Noosa Heads pub

Leave a reply Cancel reply

More in:Business

Flying to Europe via the Middle East? Cheaper fares beat safety concerns

I’m sick of immigration being blamed for problems it doesn’t cause

ASX set to slide as Wall Street slips

Posts List

Man accused of pushing woman down set of stairs at Noosa Heads pub